Mirati Therapeutics Aktie Analyse
18.07.19 | Mirati Therapeutics Hold | Deutsche Bank AG | |
19.06.19 | Mirati Therapeutics Neutral | B. Riley FBR | |
05.06.19 | Mirati Therapeutics Buy | H.C. Wainwright & Co. | |
03.12.18 | Mirati Therapeutics Buy | B. Riley FBR | |
09.07.18 | Mirati Therapeutics Outperform | Oppenheimer & Co. Inc. | |
12.03.18 | Mirati Therapeutics overweight | Barclays Capital | |
09.01.18 | Mirati Therapeutics Buy | H.C. Wainwright & Co. | |
12.10.17 | Mirati Therapeutics Buy | H.C. Wainwright & Co. | |
Werbung
|
|||
17.11.16 | Mirati Therapeutics Buy | H.C. Wainwright & Co. | |
06.06.16 | Mirati Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
24.05.16 | Mirati Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
09.05.16 | Mirati Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
19.10.15 | Mirati Therapeutics overweight | Barclays Capital | |
01.06.15 | Mirati Therapeutics Hold | Brean Capital | |
08.05.15 | Mirati Therapeutics Buy | Brean Capital |